Skip to main navigation Skip to search Skip to main content

The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)

Khaled Nassar*, Julia Lüke, Matthias Lüke, Mahmoud Kamal, Effat Abd El-Nabi, Mahmoud Soliman, Martin Rohrbach, Salvatore Grisanti

*Corresponding author for this work

Abstract

Background: The cytokine transforming growth factor- (TGF-β) is a pivotal contributor to tissue fibrosis and a key cytokine in the pathogenesis of cellular transdifferentiation, epithelial-mesenchymal transition (EMT), and cell adhesion. This study evaluates the effect of decorin, a naturally occurring TGF-β inhibitor, in an experimental rabbit model for proliferative vitreoretinopathy (PVR). Methods: Traumatic PVR was induced in 50 rabbits divided into ten groups (n=5). One group (GI) reveals a control with no treatment after trauma. Groups (GII-GIV) consisted of subgroups receiving phacovitrectomy at three different time points; (a) at the time of trauma, (b) 1 week following trauma, and (c) 2 weeks following trauma. GIII and GIV received 100 μg or 200 μg decorin, respectively. PVR severity was scored from 0 to 4. The amount of fibrosis was quantified using JMicroVision

Original languageEnglish
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume249
Issue number11
Pages (from-to)1649-1660
Number of pages12
ISSN0721-832X
DOIs
Publication statusPublished - 11.2011

Funding

Acknowledgements This study was supported in part by Herbert Funke Foundation, Germany and by the ministry of high education of the Egyptian government. We thank Mrs. Christine Örün for her technical assistance.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

Fingerprint

Dive into the research topics of 'The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)'. Together they form a unique fingerprint.

Cite this